LabCentral announced that Takeda, a global biopharmaceutical leader headquartered in Japan with a global U.S. hub located in Massachusetts, will become a LabCentral Founding...
Embolx, Inc. a medical device company developing microcatheters for arterial embolization procedures, announced that the company has filed a 510(k) to the Food and...
Astellas Pharma Inc. announced plans to create an integrated biotechnology campus in South San Francisco as its West Coast innovation and research center. The...
Xandar Kardian, a rapidly-growing, Toronto-based company that develops contactless health monitoring solutions powered by digital ultra wide-band radar signal processing, officially announced a strategic...
Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company") announced that it has discontinued development of fezagepras.
The decision to discontinue the development of fezagepras is...
